WallStreetZenWallStreetZen

NASDAQ: EVGN
Evogene Ltd Stock Ownership - Who owns Evogene?

Insider buying vs selling

Have Evogene Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVGN insiders and whales buy or sell their stock.

EVGN Shareholders

What type of owners hold Evogene Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Silverarc Capital Management LLC6.13%3,100,000$2.60MInstitution
Walleye Capital LLC1.02%517,092$434.36kInstitution
Cvi Holdings LLC0.52%261,636$219.77kInstitution
Morgan Stanley0.35%175,815$147.68kInstitution
Lpl Financial LLC0.13%66,835$56.14kInstitution
Bnp Paribas Arbitrage Snc0.13%65,900$55.36kInstitution
Geode Capital Management LLC0.12%59,007$49.57kInstitution
Sigma Planning Corp0.10%50,985$42.83kInstitution
Renaissance Technologies LLC0.09%45,400$38.14kInstitution
Ubs Group Ag0.07%36,005$30.24kInstitution

1 of 3

EVGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVGN9.22%0.00%
LTRN10.62%67.73%Net SellingNet Selling
TIL51.31%48.69%
LVTX21.75%0.00%
CELU19.02%61.81%Net BuyingNet Buying

Evogene Stock Ownership FAQ

Who owns Evogene?

Evogene (NASDAQ: EVGN) is owned by 9.22% institutional shareholders, 0.00% Evogene insiders, and 90.78% retail investors. Silverarc Capital Management LLC is the largest individual Evogene shareholder, owning 3.10M shares representing 6.13% of the company. Silverarc Capital Management LLC's Evogene shares are currently valued at $2.50M.

If you're new to stock investing, here's how to buy Evogene stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.